Clinical Trial Update: A Study of Prevalence of EGFR Mutations in Participants With NSCLC

View source ↗

Summary

This clinical trial update reports on the prevalence of EGFR mutations among participants with non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Small Cell Lung Cancer | Status: COMPLETED